298 related articles for article (PubMed ID: 30322863)
1. Circulating Glioma Cells Exhibit Stem Cell-like Properties.
Liu T; Xu H; Huang M; Ma W; Saxena D; Lustig RA; Alonso-Basanta M; Zhang Z; O'Rourke DM; Zhang L; Gong Y; Kao GD; Dorsey JF; Fan Y
Cancer Res; 2018 Dec; 78(23):6632-6642. PubMed ID: 30322863
[TBL] [Abstract][Full Text] [Related]
2. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
3. Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma.
Kang MK; Kang SK
Stem Cells Dev; 2007 Oct; 16(5):837-47. PubMed ID: 17999604
[TBL] [Abstract][Full Text] [Related]
4. Stemness Marker Detection in the Periphery of Glioblastoma and Ability of Glioblastoma to Generate Glioma Stem Cells: Clinical Correlations.
Raysi Dehcordi S; Ricci A; Di Vitantonio H; De Paulis D; Luzzi S; Palumbo P; Cinque B; Tempesta D; Coletti G; Cipolloni G; Cifone MG; Galzio R
World Neurosurg; 2017 Sep; 105():895-905. PubMed ID: 28559081
[TBL] [Abstract][Full Text] [Related]
5. SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties.
Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Aboody KS
Stem Cells Dev; 2017 Sep; 26(17):1236-1246. PubMed ID: 28610554
[TBL] [Abstract][Full Text] [Related]
6. MDM2 Degrades Deacetylated Nucleolin Through Ubiquitination to Promote Glioma Stem-Like Cell Enrichment for Chemotherapeutic Resistance.
Ko CY; Lin CH; Chuang JY; Chang WC; Hsu TI
Mol Neurobiol; 2018 Apr; 55(4):3211-3223. PubMed ID: 28478507
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor cells exhibit stem cell characteristics in an orthotopic mouse model of colorectal cancer.
Schölch S; García SA; Iwata N; Niemietz T; Betzler AM; Nanduri LK; Bork U; Kahlert C; Thepkaysone ML; Swiersy A; Büchler MW; Reissfelder C; Weitz J; Rahbari NN
Oncotarget; 2016 May; 7(19):27232-42. PubMed ID: 27029058
[TBL] [Abstract][Full Text] [Related]
8. Migrating glioma cells express stem cell markers and give rise to new tumors upon xenografting.
Munthe S; Sørensen MD; Thomassen M; Burton M; Kruse TA; Lathia JD; Poulsen FR; Kristensen BW
J Neurooncol; 2016 Oct; 130(1):53-62. PubMed ID: 27510953
[TBL] [Abstract][Full Text] [Related]
9. Expression and regulation of prostate apoptosis response-4 (Par-4) in human glioma stem cells in drug-induced apoptosis.
Jagtap JC; Dawood P; Shah RD; Chandrika G; Natesh K; Shiras A; Hegde AS; Ranade D; Shastry P
PLoS One; 2014; 9(2):e88505. PubMed ID: 24523904
[TBL] [Abstract][Full Text] [Related]
10. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells.
Talukdar S; Das SK; Pradhan AK; Emdad L; Shen XN; Windle JJ; Sarkar D; Fisher PB
Oncotarget; 2016 Aug; 7(34):54102-54119. PubMed ID: 27472461
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids promote a glioma stem cell-like phenotype and resistance to chemotherapy in human glioblastoma primary cells: Biological and prognostic significance.
Kostopoulou ON; Mohammad AA; Bartek J; Winter J; Jung M; Stragliotto G; Söderberg-Nauclér C; Landázuri N
Int J Cancer; 2018 Mar; 142(6):1266-1276. PubMed ID: 29067692
[TBL] [Abstract][Full Text] [Related]
12. PC3-Secreted Microprotein Is Expressed in Glioblastoma Stem-Like Cells and Human Glioma Tissues.
Maruyama M; Nakano Y; Nishimura T; Iwata R; Matsuda S; Hayashi M; Nakai Y; Nonaka M; Sugimoto T
Biol Pharm Bull; 2021 Jul; 44(7):910-919. PubMed ID: 33896885
[TBL] [Abstract][Full Text] [Related]
13. HIF1α regulates single differentiated glioma cell dedifferentiation to stem-like cell phenotypes with high tumorigenic potential under hypoxia.
Wang P; Lan C; Xiong S; Zhao X; Shan Y; Hu R; Wan W; Yu S; Liao B; Li G; Wang J; Zou D; Chen B; Feng H; Wu N
Oncotarget; 2017 Apr; 8(17):28074-28092. PubMed ID: 28427209
[TBL] [Abstract][Full Text] [Related]
14. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
15. Dedifferentiation of Glioma Cells to Glioma Stem-like Cells By Therapeutic Stress-induced HIF Signaling in the Recurrent GBM Model.
Lee G; Auffinger B; Guo D; Hasan T; Deheeger M; Tobias AL; Kim JY; Atashi F; Zhang L; Lesniak MS; James CD; Ahmed AU
Mol Cancer Ther; 2016 Dec; 15(12):3064-3076. PubMed ID: 27765847
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma.
Soroceanu L; Matlaf L; Khan S; Akhavan A; Singer E; Bezrookove V; Decker S; Ghanny S; Hadaczek P; Bengtsson H; Ohlfest J; Luciani-Torres MG; Harkins L; Perry A; Guo H; Soteropoulos P; Cobbs CS
Cancer Res; 2015 Aug; 75(15):3065-76. PubMed ID: 26239477
[TBL] [Abstract][Full Text] [Related]
17. Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells.
Ge F; Zhang H; Wang DD; Li L; Lin PP
Oncotarget; 2015 Sep; 6(29):27049-64. PubMed ID: 26267323
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor cells and their advances to promote cancer metastasis and relapse, with focus on glioblastoma multiforme.
Chistiakov DA; Chekhonin VP
Exp Mol Pathol; 2018 Oct; 105(2):166-174. PubMed ID: 30028961
[TBL] [Abstract][Full Text] [Related]
19. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
[TBL] [Abstract][Full Text] [Related]
20. Effects of salinomycin and niclosamide on small cell lung cancer and small cell lung cancer circulating tumor cell lines.
Hochmair M; Rath B; Klameth L; Ulsperger E; Weinlinger C; Fazekas A; Plangger A; Zeillinger R; Hamilton G
Invest New Drugs; 2020 Aug; 38(4):946-955. PubMed ID: 31446534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
